EydisBio
Pre-clinicalSelective TAK1 Inhibitor Development Targeting autoimmune and inflammatory diseases through the use of highly selective protein kinase inhibitors Unmet Medical...Read More
Founded
2020
Focus
Small Molecules
About
Selective TAK1 Inhibitor Development Targeting autoimmune and inflammatory diseases through the use of highly selective protein kinase inhibitors Unmet Medical...Read More
Company Info
TypePrivate
Founded2020
LocationCambridge, United States
StagePre-clinical
Contact
Sectors
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
3D Biotek
Pre-clinical · North Brunswick
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile